Jain Global’s Centessa Pharmaceuticals CNTA Stock Holding History

Jain Global’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-71,513	Closed	-$2.84M	–	1788
2026 Q1	$2.84M	Sell	71,513 -844,290	-92%	-$21.6M	0.01%	606
2025 Q4	$22.9M	Buy	915,803 +673,828	+278%	+$17.1M	0.11%	191
2025 Q3	$5.87M	Buy	+241,975	New	+$4.3M	0.03%	324
2025 Q1	–	Sell	-23,466	Closed	-$393K	–	1117
2024 Q4	$393K	Buy	+23,466	New	+$389K	0.01%	505

Jain Global's CNTA Position: Q2 2026 in Review

Jain Global sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 71,513 shares — an estimated $2.84M sold.

Jain Global first reported a position in CNTA in Q4 2024 and held it in 4 quarters. The position peaked at $22.9M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Jain Global reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jain Global sold 71,513 Centessa Pharmaceuticals shares in Q2 2026, an estimated $2.84M.
Jain Global first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 4 quarters.
Jain Global's Centessa Pharmaceuticals position peaked at $22.9M in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.